PYC Therapeutics Ltd (PYC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.203x

Based on the latest financial reports, PYC Therapeutics Ltd (PYC) has a cash flow conversion efficiency ratio of -0.203x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-34.54 Million ≈ $-24.44 Million USD) by net assets (AU$170.01 Million ≈ $120.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see PYC Therapeutics Ltd stock valuation for the company's overall valuation and market capitalisation.

PYC Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how PYC Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PYC Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PYC Therapeutics Ltd ranked by their cash flow conversion efficiency. See PYC debt coverage from operations to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Southern Cross Electrical Engineering Ltd AU:SXE	0.217x
Jiangxi Guoguang Commercial Chains Co Ltd SHG:605188	0.036x
Lenzing Aktiengesellschaft VI:LNZ	0.050x
Cementos Pacasmayo SAA ADR NYSE:CPAC	0.141x
CNB Financial Corporation NASDAQ:CCNE	0.008x
Morguard Corporation TO:MRC	0.007x
Guangzhou Automobile Group Co. Ltd F:02G	0.001x
Jiangxi Xinyu Guoke Technology Co Ltd Class A SHE:300722	0.003x

Annual Cash Flow Conversion Efficiency for PYC Therapeutics Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of PYC Therapeutics Ltd from 2004 to 2025. View latest PYC Therapeutics Ltd stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$170.01 Million ≈ $120.29 Million	AU$-51.56 Million ≈ $-36.48 Million	-0.303x	+36.30%
2024-06-30	AU$81.05 Million ≈ $57.35 Million	AU$-38.59 Million ≈ $-27.30 Million	-0.476x	+44.55%
2023-06-30	AU$28.44 Million ≈ $20.12 Million	AU$-24.42 Million ≈ $-17.28 Million	-0.859x	-58.47%
2022-06-30	AU$40.20 Million ≈ $28.45 Million	AU$-21.78 Million ≈ $-15.41 Million	-0.542x	-147.78%
2021-06-30	AU$53.92 Million ≈ $38.15 Million	AU$-11.79 Million ≈ $-8.34 Million	-0.219x	-14.86%
2020-06-30	AU$30.20 Million ≈ $21.37 Million	AU$-5.75 Million ≈ $-4.07 Million	-0.190x	+76.60%
2019-06-30	AU$6.30 Million ≈ $4.46 Million	AU$-5.13 Million ≈ $-3.63 Million	-0.814x	+80.02%
2018-06-30	AU$1.65 Million ≈ $1.17 Million	AU$-6.71 Million ≈ $-4.75 Million	-4.072x	-1815.51%
2017-06-30	AU$8.86 Million ≈ $6.27 Million	AU$-1.88 Million ≈ $-1.33 Million	-0.213x	+60.86%
2016-06-30	AU$5.83 Million ≈ $4.13 Million	AU$-3.17 Million ≈ $-2.24 Million	-0.543x	+78.94%
2015-06-30	AU$962.03K ≈ $680.70K	AU$-2.48 Million ≈ $-1.76 Million	-2.579x	-199.69%
2014-06-30	AU$3.72 Million ≈ $2.63 Million	AU$-3.20 Million ≈ $-2.26 Million	-0.861x	+55.58%
2013-06-30	AU$1.19 Million ≈ $845.45K	AU$-2.32 Million ≈ $-1.64 Million	-1.938x	-25.63%
2012-06-30	AU$2.69 Million ≈ $1.91 Million	AU$-4.15 Million ≈ $-2.94 Million	-1.542x	-128.13%
2011-06-30	AU$4.35 Million ≈ $3.08 Million	AU$-2.94 Million ≈ $-2.08 Million	-0.676x	-108.14%
2010-06-30	AU$-437.08K ≈ $-309.26K	AU$-3.63 Million ≈ $-2.57 Million	8.302x	+509.05%
2009-06-30	AU$1.91 Million ≈ $1.35 Million	AU$-3.88 Million ≈ $-2.74 Million	-2.030x	-9.99%
2008-06-30	AU$2.69 Million ≈ $1.91 Million	AU$-4.97 Million ≈ $-3.52 Million	-1.845x	-31.11%
2007-06-30	AU$2.20 Million ≈ $1.55 Million	AU$-3.09 Million ≈ $-2.19 Million	-1.407x	-5.96%
2006-06-30	AU$2.11 Million ≈ $1.50 Million	AU$-2.81 Million ≈ $-1.99 Million	-1.328x	-476.72%
2005-06-30	AU$5.78 Million ≈ $4.09 Million	AU$-1.33 Million ≈ $-942.05K	-0.230x	-549.11%
2004-06-30	AU$546.00K ≈ $386.33K	AU$28.00K ≈ $19.81K	0.051x	--

About PYC Therapeutics Ltd

AU:PYC Australia Biotechnology

Market Cap

$955.07 Million

AU$1.35 Billion AUD

Market Cap Rank

#9428 Global

#232 in Australia

Share Price

AU$2.26

Change (1 day)

+1.35%

52-Week Range

AU$0.85 - AU$2.57

All Time High

AU$2.57